Clariant Healthcare Packaging to Partner with FreeThink to Offer Predictive Modeling for the Stability of Drugs

  • Drug-stability specialist FreeThink Technologies Inc. to provide analytical services and modeling software to support Clariant customers
  • Technology can streamline development and testing of controlled atmosphere packaging
  • Clariant and FreeThink Technologies Inc. demonstrate predictive and modeling system
Muttenz, November 30, 2015 – Clariant, a world leader in specialty chemicals, announced that its Healthcare Packaging business unit has entered into a joint promotion agreement with FreeThink Technologies Inc. to support pharmaceutical and nutraceutical customers with predictive calculation and modeling.

Clariant manufactures a full range of protective packaging technologies and pharmaceutical desiccants that extend the shelf life of sensitive drugs while maintaining their stability. Clariant will collaborate with FreeThink Technologies, utilizing the company's analytical services and its ASAPprime® software tool to model the influence of climatic conditions on packaged drug degradation over time. Modeling data then can be used to rapidly, accurately and confidently determine drug substance and drug product shelf-life.

"Bringing together Clariant's expertise in the area of protective packaging and desiccants, and FreeThink's renowned modeling methodologies, we can offer the pharmaceutical market the most robust service for predictive calculations to optimize protection of drugs," said Mark Florez, Product Manager, Clariant Healthcare Packaging.

Dr. Kenneth Waterman, a veteran of the pharmaceutical industry specializing in drug stability, founded FreeThink Technologies, Inc. in 2011. Its cutting-edge technologies focus on accelerated shelf-life and stability determinations for pharmaceuticals, consumer products, nutraceuticals and medical devices. FreeThink maintains laboratories in Groton, CT where it conducts studies for international client companies and develops new pharmaceutical-oriented technologies.

"We are excited about our partnership with Clariant," said Dr. Waterman, "and we are looking forward to combining our relevant competencies to support pharmaceutical customers' evaluation of packaging technologies for sensitive molecules."

Even with predictive modeling, drug package configurations still need to undergo stability testing, but the process can be streamlined by predicting which protective package system is most likely to provide the required protection. It is also important to simulate and predict the impact of any proposed changes to existing packaging configurations.

The partnership with FreeThink will give Clariant additional resources to draw on as it continues to work directly with customers, calculating the environmental conditions inside drug packaging over time, and predicting the protection time which generally expires when a critical relative humidity level is reached.

Clariant Healthcare Packaging is dedicated to enhancing and protecting healthcare products by providing a full portfolio of controlled atmosphere packaging solutions that protect products from degradation and help maintain stability and integrity throughout shelf life. With a global production network and innovative product development, its products include desiccants, oxygen scavengers, active container-closure systems and multilayer barrier packaging.

Request to Clariant

Please enter your contact information so we are able to process your request. Thank you for your interest.

Contact Person
This information corresponds to the present state of our knowledge and is intended as a general description of our products and their possible applications. Clariant makes no warranties, express or implied, as to the information’s accuracy, adequacy, sufficiency or freedom from defect and assumes no liability in connection with any use of this information. Any user of this product is responsible for determining the suitability of Clariant’s products for its particular application.<br />
<br />
* Nothing included in this information waives any of Clariant’s General Terms and Conditions of Sale, which control unless it agrees otherwise in writing. Any existing intellectual/industrial property rights must be observed. Due to possible changes in our products and applicable national and international regulations and laws, the status of our products could change. Material Safety Data Sheets providing safety precautions, that should be observed when handling or storing Clariant products, are available upon request and are provided in compliance with applicable law. You should obtain and review the applicable Material Safety Data Sheet information before handling any of these products. For additional information, please contact Clariant.<br />
<br />
* For sales to customers located within the United States and Canada the following applies in addition: No express or implied warranty is made of the merchantability, suitability, fitness for a particular purpose or otherwise of any product or service.<br />
<br />
© Trademark of Clariant registered in many countries.<br />
® 2019 Clariant International Ltd 

You are about to leave the Clariant domain

The link you activated will take you outside the Clariant site in about 10 seconds. If you want to stop this, press "Cancel".